Plewman Patrick sold $3.0M of DGX
Plewman Patrick (SVP for Diagnostic Services) sold 11,717 shares of QUEST DIAGNOSTICS INC (DGX) at $257.34 ($3.02M total) across 3 trades on 2026-11-09 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data on insider holdings, offering a modest trading signal.
Market read
Primary source filing; modest insider sell may cause slight short‑term pressure but limited broader impact.
What to watch
Potential upcoming earnings or guidance that may offset the sell‑off.
Background
Form 4 filing from Quest Diagnostics (DGX) reporting an insider's open‑market sale under a pre‑arranged 10b5‑1 plan.
Ticker impact
Officer Plewman Patrick sold 11,717 shares for $3.0M via a 10b5‑1 plan, reducing his stake to 14,684 shares.
likely slight downward pressure as the market prices in the insider sell
A $3M sale by a senior officer is material for a mid‑cap biotech, but the amount is modest relative to market cap, so impact is limited.
Market effects
Minimal; insider sales are common in diagnostics sector and unlikely to shift sector sentiment.
None
Low
Counterpoint
The sale could be a routine liquidity event unrelated to fundamentals.
Key entities
- companyQuest Diagnostics Inc.
US‑listed diagnostics company (ticker DGX).
- personPlewman Patrick
Senior Vice President for Diagnostic Services, officer of Quest Diagnostics.


